Article
A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease.
Circulation research - 2 Apr 2010
Ding Hu, Wu Bin, Wang Hu, Lu Zhilan, Yan Jiangtao, Wang Xiaojing, Shaffer John R, Hui Rutai, Wang Dao Wen
Abstract excerpt
RATIONALE: Asymmetrical dimethylarginine (ADMA), an endogenous arginine analogue, inhibits nitric oxide synthases and plays an important role in endothelial dysfunction. OBJECTIVE: In the present study, we tested whether a novel genetic variant in dimethylarginine dimethylaminohydrolase 1 (DDAH1), an important ADMA hydrolyzing gene, was associated with stroke and coronary heart disease (CHD) susceptibility in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
